A Novel Marker, Based on Ultrasound Tomography, for Monitoring Early Response to Neoadjuvant Chemotherapy.
Nebojsa DuricPeter LittrupMark SakCuiping LiDi ChenOlivier RoyLisa Bey-KnightRachel BremPublished in: Journal of breast imaging (2020)
This study demonstrates the feasibility of using UST to monitor NAC response, warranting future studies to better define the potential of UST for noninvasive, rapid identification of partial versus complete responders in women undergoing NAC.
Keyphrases
- neoadjuvant chemotherapy
- transcription factor
- locally advanced
- lymph node
- sentinel lymph node
- magnetic resonance imaging
- polycystic ovary syndrome
- squamous cell carcinoma
- current status
- genome wide analysis
- metabolic syndrome
- rectal cancer
- computed tomography
- climate change
- radiation therapy
- type diabetes
- pregnant women
- insulin resistance
- breast cancer risk